Page last updated: 2024-11-03

propafenone and Cardiovascular Diseases

propafenone has been researched along with Cardiovascular Diseases in 3 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"Flecainide and propafenone are antiarrhythmic drugs of the class 1C (Vaughan and Williams) commonly used for ventricular arrhythmias."10.17[Propafenone and flecainide in the therapy of ventricular arrhythmias]. ( Davini, A; Lattanzi, F; Paci, A; Paperini, L; Reisenhofer, B; Squarcini, G; Topi, A; Topi, PL, 1995)
"Rivaroxaban reduces the risk of thromboembolism in atrial fibrillation (AF) patients, who often also receive antiarrhythmic drugs (AADs) to maintain sinus rhythm."8.02Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation. ( Chen, CY; Chiou, WR; Chuang, JY; Huang, CC; Kuo, JY; Lee, YH; Liao, FC; Lin, PL; Liu, LY; Su, MI; Tsai, CT; Wu, YJ, 2021)
"Flecainide and propafenone are antiarrhythmic drugs of the class 1C (Vaughan and Williams) commonly used for ventricular arrhythmias."6.17[Propafenone and flecainide in the therapy of ventricular arrhythmias]. ( Davini, A; Lattanzi, F; Paci, A; Paperini, L; Reisenhofer, B; Squarcini, G; Topi, A; Topi, PL, 1995)
"Rivaroxaban reduces the risk of thromboembolism in atrial fibrillation (AF) patients, who often also receive antiarrhythmic drugs (AADs) to maintain sinus rhythm."4.02Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation. ( Chen, CY; Chiou, WR; Chuang, JY; Huang, CC; Kuo, JY; Lee, YH; Liao, FC; Lin, PL; Liu, LY; Su, MI; Tsai, CT; Wu, YJ, 2021)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chiou, WR1
Huang, CC1
Lin, PL1
Chuang, JY1
Liu, LY1
Su, MI1
Liao, FC1
Chen, CY1
Kuo, JY1
Tsai, CT1
Wu, YJ1
Lee, YH1
Paperini, L1
Davini, A1
Lattanzi, F1
Topi, A1
Reisenhofer, B1
Squarcini, G1
Paci, A1
Topi, PL1
Seto, W1
Trope, A1
Carfrae, L1
Walker, S1

Reviews

1 review available for propafenone and Cardiovascular Diseases

ArticleYear
[Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Minerva cardioangiologica, 1995, Volume: 43, Issue:10

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Drug Evaluation;

1995

Trials

1 trial available for propafenone and Cardiovascular Diseases

ArticleYear
[Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Minerva cardioangiologica, 1995, Volume: 43, Issue:10

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Drug Evaluation;

1995

Other Studies

2 other studies available for propafenone and Cardiovascular Diseases

ArticleYear
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Dis

2021
Visual compatibility of sodium nitroprusside with other injectable medications given to pediatric patients.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Aug-01, Volume: 58, Issue:15

    Topics: Amiodarone; Cardiovascular Diseases; Catheterization, Central Venous; Chemical Precipitation; Child;

2001